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The floor plate (FP) is a critical signaling center during
neural development located along the ventral midline
of the embryo. Little is known about human FP devel-
opment because of the lack of tissue accessibility.
Here we report the efficient derivation of human
embryonic stem cell (hESC)-derived FP tissue ca-
pable of secreting Netrin-1 and SHH and patterning
primary and hESC derived tissues. FP induction in
hESCs is dependent on early SHH exposure and
occurs at the expense of anterior neurectoderm
(AN). Global gene expression and functional studies
identify SHH-mediated inhibition of Dkk-1 as key
factor in FP versus AN specification. hESC-derived
FP tissue is shown to be of anterior SIX6+ character
but is responsive to caudalizing factors suppressing
SIX6 expression and inducing a shift in usage of
region-specific SHH enhancers. These data define
the early signals that drive human FP versus AN
specification and determine regional identity in
hESC-derived FP.
INTRODUCTION
Neural development is dictated in time and space by a complex
set of signals that instruct neural precursor identity. Although
significant progress has been made in animal models, human
neural development remains much less understood. Human
embryonic stem cells (hESCs) offer an accessible and manipu-
latable platform to model the early stages of human develop-
ment. Previous studies have reported the directed differentiation
of mouse (Wichterle et al., 2002; Barberi et al., 2003; Watanabe
et al., 2005) and human (Perrier et al., 2004; Li et al., 2008; Eiraku
et al., 2008) ESCs into specific neuron types in response to
patterning factors defining anterior/posterior (A/P) and dorso-/
ventral (D/V) CNS identity. These studies demonstrate evolu-
tionary conservation of signaling systems that specify the major
CNS regions. In mammals, sonic hedgehog (SHH) is the key ven-
tralizing factor acting in a dose-dependent manner to specify the
various ventral cell types including cells expressing floor plate336 Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc.(FP) in primary neural explants (Briscoe and Ericson, 1999) and
in mouse ESCs (Mizuseki et al., 2003). Although application of
SHH to hESC-derived neural cells has been shown to induce
various ventral neuron types, the derivation of floor plate (FP)
tissue itself has not yet been reported.
The FP runs along the most medial aspect of the ventral neural
tube extending most caudally from the spinal cord, through the
midbrain, and up to the diencephalon with its anterior limit being
just below the zona limitans intrathalamica (Jessell et al., 1989).
Interestingly, at the most anterior aspect the FP stops where the
anterior neurectoderm (AN) begins, and studies have shown that
AN commitment renders cells incapable of responding to FP-
inductive signals (Patten et al., 2003). Classic studies have
shown FP cells to exhibit a unique, flat morphology and to
express FP-specific markers including SHH, Foxa2, F-Spondin,
and Netrin-1 (Placzek, 1995). Studies in mouse and chick
embryos have identified two major organizer functions for the
FP: the secretion of the morphogen SHH patterning the ventral
neural tube (Placzek and Briscoe, 2005) and the expression of
Netrin-1 guiding commissural axons across the midline (Charron
et al., 2003). The FP is generally considered a nonneurogenic
region. However, genetic lineage mapping studies in the mouse
have recently reported that the midbrain FP selectively exhibits
neurogenic potential and is the source of ventral midbrain dopa-
mine neurons (Kittappa et al., 2007; Ono et al., 2007; Joksimovic
et al., 2009).
To date, little is known about FP development in humans
despite the important role of altered midline SHH signaling in
several developmental disorders (Mullor et al., 2002) including
certain forms of holoprosencephaly and microphthalmia, skel-
etal disorders including various cleft plate syndromes, and tumor
conditions such as Gorlin’s syndrome caused by a mutation in
the SHH receptor Patched 1. Thus, the identification of the
signals necessary and sufficient for human FP specification is
critical for modeling human neural development and for the
study of disorders mediated by ventral patterning and axonal
pathfinding defects. Unlimited number of in vitro-generated FP
precursors could also serve as a source of specific neuron types
of FP origin.
Here, we demonstrate the directed differentiation of hESCs
into FP tissue, as the first example of generating a human devel-
opmental organizer structure in vitro. We show that human FP
specification is dependent on early high-dose SHH signaling
that represses Dkk1-mediated specification of AN. FP function
Figure 1. High SHH Levels Increase Foxa2
and Decrease BF1 Expression
(A) Passage 1, day 21 of neural differentiation
shows no effect of Shh treatment when added
at day 15. Results are quantified on the right;
*p < 0.01, n = 3. The scale bar represents 200 mm.
(B) Day 21 of neural differentiation shows a reduc-
tion of rosette like structures after Sonic C25II
treatment day 9. Loss of rosettes is quantified on
the right; *p < 0.01, n = 4. The scale bar represents
100 mm.
(C) Sonic C25II treatment results in a decrease of
BF1 and an increase in Foxa2 at day 21; results
are quantified on the right; *p < 0.05, n = 4. The
scale bar represents 200 mm.
(D) Day 21 of neural differentiation reveals
a decrease in ZO1/BF1+ rosette structures. This
decrease is quantified; *p < 0.01, n = 4. The scale
bar represents 50 mm.
(E) Decrease in Pax6 expression at Day 21 after
Sonic C25II treatment. This decrease is quantified;
*p < 0.01, n = 4. The scale bar represents 200 mm.
(F) Dose response curve comparing Sonic and
Sonic C25II efficacy on FOXA2 induction.
(G) Dose response curve of Sonic C25II comparing
the induction of FP markers (FOXA2 and Netrin-1)
to another SHH responsive gene NKX6.1.
See also Figure S1.
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Floor Plate Induction from hESCsis demonstrated by secretion of Netrin-1 and SHH and the ability
to induce ectopic FP tissue and neurite outgrowth in primary
mouse and rat explants. Human ESC-derived FP adopts anterior
identity by default but can be specified to posterior fates in
response to caudalizing cues providing access to region-
specific FP cells. Our data further illustrate the power of using
a defined in vitro neural differentiation assay (dual SMAD-inhibi-
tion protocol) for mechanistic studies defining the temporal and
molecular requirements of early human fate choice.
RESULTS
Early High-Dose SHH Exposure Induces FOXA2
and Represses BF1
We have recently shown that hESC-derived neural cells at the
rosette stage can be differentiated into both CNS and PNS
progeny and patterned toward multiple cells fates along the
A/P and D/V axis (Elkabetz et al., 2008). These results demon-
strated that rosette stage cells are highly plastic and responsiveCell Stem Cell 6, 336–to patterning cues including SHH. Speci-
fication of FP during mouse development
is thought to depend on SHH signaling
within early neural lineages. Here, we
tested whether rosette-stage neural cells
are competent to undergo FP specifica-
tion in response to SHH. It is known that
high concentrations of SHH are needed
to induce FP during mouse development
(Roelink et al., 1994; Ericson et al.,
1996). Recombinant N-terminal SHH
has a limited activity range because ofthe lack of posttranslational modifications required for full SHH
action. Recently, amodified version has become available where
SHH is tethered to two Isoleucines (Sonic C25II, R&D Systems),
mimicking more closely the potency of mammalian SHH protein.
In most functional assays C25II is 10 times more potent than
nonmodified N-terminal SHH (data not shown). Surprisingly,
dose-response studies with both conventional SHH and SHH-
C25II on established rosette-stage neural cells did not yield cells
expressing FP markers such as Foxa2 (FP marker) under any
of the conditions tested. The majority of cells retained rosette
cytoarchitecture and staining for the AN marker BF1 (FOXG1)
as described previously (Figure 1A) (Elkabetz et al., 2008). These
data suggest that exposure to high SHH is not sufficient to
convert established rosette-stage cells into FP.
On the basis of the hypothesis that FP specification in the
mouse occurs at early developmental stages, at the time of or
prior to neural induction, we repeated SHH induction studies at
day 9, the time of rosette specification, using classic stromal-
feeder-mediated neural induction protocols (Elkabetz et al.,347, April 2, 2010 ª2010 Elsevier Inc. 337
Figure 2. Floor Plate Induction Has an Early,
Short Temporal Patterning Window
(A) Schematic showing different time points of
Sonic C25II additions during neural induction
protocol.
(B and C) Heading on the left delineates the day
Sonic C25II was added, heading on the top delin-
eates when the assay was stopped. The earlier
Sonic C25II is added, and the longer the cells are
exposed to it, leads to very high percentages of
Foxa2. In (C), this result is quantified; *p < 0.01,
n = 3. Scale bars represent 200 mm, scale bars in
high-magnification panels represent 50 mm.
(D) Extended treatment with Sonic C25II (9 days
of exposure) does not yield increased FOXA2
induction.
(E) Schematic of optimal protocol for Foxa2 induc-
tion to be used for the rest of the study.
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Floor Plate Induction from hESCs2008). Under this paradigm we noticed a drastic change in cell
morphology restricted to the cells treated with SHH-C25II
(Figure 1B). Cells exhibited a flat morphology devoid of rosette
structures. Furthermore, we observed a robust upregulation of
FOXA2+, a concomitant decrease in BF1+ cells (Figure 1C),
and the decrease in the total number of ZO1+ rosettes (Fig-
ure 1D). In addition to decreased expression of BF1 we also
observed decreased expression of PAX6, another maker ex-
pressed in the AN (Figure 1E). Dose-response studies demon-
strated that induction of FOXA2+ cells and the concomitant
decrease in BF1 and PAX6 expression can be achieved at
concentrations of 125–500 ng/ml of SHH C25II (Figure 1F and
data not shown). No efficient induction of FOXA2+ cells was
observedwith any of the concentrations testedwith nonmodified
N-terminal SHH. We also performed dose-response studies to
understand how FP marker induction compared to that of
NKX6.1 expression, a gene known to respond to lower concen-
trations of SHH. At low concentrations of Sonic C25II, there is no
expression of FP markers FOXA2 and Netrin-1 but a robust338 Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc.increase in NKX6.1 expression. At higher
concentrations, FP markers rapidly rise,
whereas NKX6.1 expression tapers off
(Figure 1G). These data demonstrate
that early exposure to high levels of
SHH decreases anterior AN markers
and induces the FP marker FOXA2.
The Competency for FP Induction
Is Restricted to a Narrow Window
of Differentiation
Although we did observe a robust upre-
gulation of FOXA2, only30%of the cells
were positive after about 21 days of
culture with classic stromal-feeder-medi-
ated neural induction. We have recently
described a more rapid and defined
neural induction paradigm based on in-
hibiting SMAD signaling via exposure to
noggin and SB431542 (NSB protocol
[Chambers et al., 2009]). Using thisprotocol, we aimed to optimize FP differentiation by adding
Sonic C25II at different time points during neural induction
(day 1, day 3, day 5, or day 7 upon NSB exposure) and assaying
for FOXA2 expression at Day 11 (Figure 2A). The most efficient
FOXA2 induction was observed in cultures treated with SHH
starting at day 1 of differentiation with Foxa2+ cells representing
65% of total cells (Figures 2B and 2C). Extended SHH treat-
ment beyond day 11 of differentiation did not increase FOXA2
yield (Figure 2D). These data demonstrate that an early high
SHH signal is needed to establish FP identity and suggest a crit-
ical window of competency for FP specification. Furthermore,
the differentiation conditions establish a robust platform for
inducing human FOXA2+ cells in vitro.
FOXA2 is a keymarker of FP development. However, FOXA2 is
also highly expressed in the endoderm. To further characterize
the hESC derived putative FP tissue, we performed qRT-PCR
analyses for candidate markers at day 11. Using the NSB
protocol as a control, we confirmed a dramatic increase in
the expression of FOXA2 and other FP markers including SHH,
Figure 3. hESC-Derived FP Is Functional
(A) Schematic showing when conditioned media
was collected.
(B) ELISA showing an increase in levels of Netrin-1
secreted into the media at days 9 and 11 when
Sonic C25II is added early to the neural induction;
*p < 0.01, n = 3.
(C) Conditioned media from NSB and NSB+Sonic
C25II was collected and placed on cultures con-
taining NSB-derived neural precursor cells qRT-
PCR showing an induction of ventral genes
(Nkx6.1 andNkx2.1) as well as the SHH responsive
gene (Gli2). These inductions are repressed in the
presence of the Shh antagonist cyclopamine.
(C0) The induction ofNkx6.1 is shown at the level of
the protein with a GFP-expressing line; *p < 0.01
compared to NSB CM, #p < 0.05 compared to
FP CM, n = 3. The scale bar represents 200um.
(D and E) Neural explants isolated from E8.5
neurectoderm cocultured with NSB+Sonic C25II
tissue show ectopic Foxa2 staining. Inset shows
colocalization of M6 (Green) and FOXA2 (Red).
(E) This data is quantified; *p < 0.001, n = 4
explants. The scale bar represents 50 mm.
See also Figure S3.
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Floor Plate Induction from hESCsF-Spondin, and Netrin-1 (Figure S1 available online). We further
characterized the nature of FOXA2+ putative FP cells by using a
panel of neural precursor, glial, neuronal, and nonneural markers
(Figure S1). FOXA2+ cells colabeled with only a limited subset
of these markers including Nestin (86%) and SOX2 (17%). To
distinguish FOXA2 expression in hESC-derived FP versus endo-
derm tissue, we differentiated hESCs to endoderm (D’Amour
et al., 2005). As expected, under both FP and endoderm differen-
tiation conditions, we observed an increase in FOXA2 expression
compared with NSB-treated control cells. However, induction of
the endoderm marker SOX17 was limited to the endoderm
condition and no SOX17 was present in hESC-derived FP cells
(Figure S1). We also did not observe expression of other endo-
dermal markers such as AFP and Albumin expression in hESC-
derived FP cells. These data demonstrate that hESC-derived
FOXA2+ cells in the NSB+SHH protocol express FP and early
neural precursor markers and lack expression of endodermal
markers.
hESC-Derived FP Cells Are Functional
The FP has important functional roles during development in
neural patterning and axonal path finding (Jessell, 2000). To
assess the functional properties of hESC-derived FP, we iso-
lated conditioned media at days 9 and 11 and tested for expres-
sion of Netrin-1 in the medium using ELISA (Figure 3A). Under
normal NSB conditions, Netrin-1 is detectable at day 9 and
decreases at day 11, whereas in the NSB+SHH condition, there
is a 3.5-fold increase in Netrin-1 levels, increasing at day 11Cell Stem Cell 6, 336–(Figure 3B). SHH is a critical patterning
factor secreted by FP cells and specifying
ventral cell types in a dose-dependent
manner. To test whether hESC-derived
FP secretes factors that can specify
ventral precursor domains, we isolatedconditioned media (CM) at days 9 and 11 of the differentiation.
At day 6, exogenous Shh was removed and cultures were
washed to eliminate any exogenously added SHH from the
medium. Naive neural progenitor cells were isolated at day 11
of the control (NSB) protocol and cultured with either NSB CM
or FP CM. After day 5 of culture in the presence of CM, we
probed for the expression of ventral precursor markers and
expression of the SHH responsive gene Gli2. We found that
compared with CM obtained from NSB control cultures, CM
from hESC-derived FP tissue efficiently induced expression of
ventral genes including Nkx2.1 and Nkx6.1 (Figure 3C). Increase
in the expression of ventral markers was confirmed at the level of
protein (Figure 3C0). This result was abolished in the presence of
the SHH antagonist cyclopamine, suggesting it was SHH medi-
ated (Figure 3C).
Classical studies demonstrated that FP explants can induce
an ectopic FP in early neuroectodermal tissue (Placzek et al.,
1993). To test whether the hESC-derived FP is capable of
inducing FP markers in primary mouse explants, we isolated
neuroectodermal tissue from an E8.5 mouse embryo and placed
it in direct contact with hESC-derived FP cells. After 3 days of
coculture, explants were identified on the basis of expression
of the mouse-specific M6 marker. As a control condition, mouse
explants were cocultured with hESC-derived neural tissue with
the NSB protocol. Although coculture with control hESC-derived
neural tissue did not yield FOXA2+cells, explants coculturedwith
hESC-derived FP cells showed robust induction of Foxa2+ cells,
particularly at the periphery of the explant (Figures 4D and 4E).347, April 2, 2010 ª2010 Elsevier Inc. 339
Figure 4. Detailed Transcriptional Analysis Reveals Genes Involved in FP Development
(A–J) qRT-PCRdata showing time course of expression over the length of the 11 day protocol. The genes looked at represented different populations including FP
markers (A–D), SHH responsive genes (E–G), neural markers (H), ANmarkers (I and J), and genes involved inmesodermal and endodermal commitment (K and L).
(M–R) Detailed time coursemicroarray analysis (M–N) GO terms for day 7 (M) and day 11 (N) showing increase or decrease compared toNSB control. FP condition
shows enrichment in genes associated with axon guidance and secreted proteins, while showing a decrease in genes associated with anterior neurectoderm
development.
(O–R) Pairwise comparisons showing genes up and downregulated compared to NSB control condition at Day 3 (O), Day 5 (P), Day 7 (Q), and Day 11 (R).
See also Figure S3 and Tables S1-S12.
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derived FP cells in primary rat E12.5 rat cerebellar plate explants
(Figure S2); such an assay was used previously to characterize
axonal growth modulating effects of primary rodent FP tissue
(Shirasaki et al., 1995). These experiments demonstrate that
hESC-derived FP can mimic the functional properties of primary
FP tissue as an organizer by secreting Netrin-1 and SHH capable
of ventralizing naive hESC-derived and primary mouse neural
precursor cells.
Temporal Gene Expression Analysis Reveals
that FP Specification Occurs at the Expense of AN
To gain further insight into the factors critical for human FP
specification, we established quantitative temporal gene ex-
pression profiles of candidate markers at 6 time points during
the 11 day protocol. We first characterized FOXA2 expression
observing a steady increase in transcript levels starting at day
3 of differentiation (compared to NSB) consistent with immunos-
taining data (Figure 4A). Interestingly, other FP markers, Shh,
Netrin-1, and F-Spondin showed a more delayed induction
with a dramatic increase in expression at day 7 of differentiation
(Figures 4B–4D). PTCH1 expression is used commonly as a
transcriptional readout of SHH activity. We observed a dramatic340 Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc.increase in PTCH1 expression as early as day 3 of differentiation
with levels further increasing by a factor of 3 over the next 2 days
(Figure 4E). It has been shown previously that the SHH down-
stream effector Gli2 is essential for FP induction but decreases
at later stages of FP development (Matise et al., 1998) and
that GLI2 can directly activate FOXA2 expression (Jeong and
Epstein, 2003). In our study, we observed an early increase in
both Gli2 and FOXA2 expression (Figures 4A and 4F) followed
by a decrease in GLI2 at day 11 consistent with a role of GLI2
specifically during FP induction. A similar trend albeit at much
lower induction levels is observed for GLI1 (Figure 4G).
SOX1 is an early neural marker and is not expressed in the
medial FP (Charrier et al., 2002). Although Sox1 was rapidly
upregulated in NSB conditions, a much smaller increase in
Sox1 levels is observed upon addition of SHH (Figure 4H). NSB
conditions yield neural cells with an AN bias expressing BF1 at
high levels (Chambers et al., 2009). However, when Shh is
added to the culture, there is a drastic reduction in Pax6 and
BF1 at day 7 (Figures 4I and 4J). Finally, we did not observe
any induction of the endoderm marker Sox17 and mesoderm
marker Brachyury (Figures 4K and 4L) indicating that FP induc-
tion, similar to AN induction with the NSB protocol, occurs
without contribution of an obvious mesodermal or endodermal
Cell Stem Cell
Floor Plate Induction from hESCsintermediate. These data demonstrate appropriate marker
expression in hESC-derived FP, initiated by Gli2 and Foxa2
expression and followed by expression of functional FP markers
such asNetrin-1, Shh, and F-Spondin. The drop in Pax6 andBF1
expression at the time of FP specification suggests that induc-
tion of FP occurs at the expense of AN.
Global Transcriptome Analysis during hESC-Derived
FP Specification
To date there have been no studies defining the transcriptional
profile of human FP cells. Here, we established temporal profiles
of global gene expression at five time points during differentia-
tion (days 1, 3, 5, 7 and 11) in control NSB cultures (yielding AN)
and in Sonic C25II-treated cultures (yielding FP; see Figure 2E).
Prior to microarray analysis the quality of each sample was veri-
fied for expression of a panel of FP markers (Figure S3). Global
gene expression analysis was carried out in three independent
samples for each time point and culture condition. Data were
converted into log2 ratios comparing levels of gene expression
in FP versus NSB protocol during differentiation (Figures 4l–4Q).
The time course data were subjected to gene ontology (GO)
enrichment analysis using DAVID (http://david.abcc.ncifcrf.
gov/; Dennis et al., 2003) as unbiased assessment of the FP
transcriptional profile. Among the transcripts highly enriched in
SHH-treated versus NSB control cultures at day 7 and 11 of
differentiation were genes associated with the Wnt and
hedgehog pathways, axon guidance, and secreted proteins
(Figures 4L and 4M; Tables S1–S4). Enrichment for patterning
and axonal guidance factors further confirms FP identity of
SHH-treated cultures. In support of our data on the SHH-medi-
ated suppression of AN, transcripts most robustly downregu-
lated in the FP versus NSB protocol included genes involved in
forebrain development (Figures 4L and 4M).
To gain insight into specific genes differentially expressed
during FP specification, we performed pairwise comparisons
at each differentiation stage. Although the majority of genes
significantly regulated at day 3 and day 5 of differentiation (as
compared today1)were shared inNSBandFPprotocol, a subset
of transcripts was differentially regulated (Figures 4N–4Q). In
particular,wenoticedan increase inPatched-1 (PTCH1), a known
transcriptional target of Shh signaling (Figures 4N–4Q). We also
observed significant changes in expression in various Wnt
pathway components. On as early as day 5, there was a signifi-
cant decrease of the Wnt pathway inhibitor Dkk-1, and this
decrease was sustained over the course of the protocol (Figures
4N–4Q and Figure S1). Furthermore, we observed significant
upregulation of several Frizzled genes that have been previously
shown to be involved in midline axon guidance during mouse
development (Lyuksyutova et al., 1998) (Figures 4P and 4Q).
Other genes that were differentially expressed during FP specifi-
cation include Six6, HESX1,Capn6, IGFBP3, and Fibln1 (Figures
4N–4Q; Tables S6–S9). We next validated differential expression
by qRT-PCR (Figure S3) and, for a subset of markers, confirmed
coexpression with FOXA2 to test their validity in characterizing
FP identity. Colabeling studies demonstrated that greater than
60% of SIX6+ and HESX1+ cells coexpressed FOXA2+ at D9
(Figures S3E and S3F). While future systematic in situ hybridiza-
tion screens in mouse and human embryos are required to
validate all candidate FP markers many of the genes identifiedin our microarray study show expression patterns compatible
with anterior midline and floor plate identity (Zoltewicz et al.,
1999) (Hunter et al., 1991) respectively (see also discussion
section below).
We also performed a gene cluster analysis showing when
genes are expressed the highest, time of maximum (TOM), and
the lowest, time of minimum (TIM), expression (Venezia et al.,
2004). We mapped GO ontology terms to this analysis and
were able to identify precise developmental windows during
the FP specification process (Tables S5–S12). These data further
confirm the identity of hESC-derived FP tissue and provides
insight into genes differentially expressed during FP versus
neuroectodermal fate specification.
Suppression of Dkk-1 Enhances FP versus
AN Generation
The observation that FP commitment occurs at the expense of
AN was strengthened by our global gene expression data
revealing a rapid downregulation of the Wnt signaling inhibitor
Dkk-1. Dkk-1-mediated inhibition of Wnt signaling during mouse
development is essential for anterior brain development (Mukho-
padhyay et al., 2001), and FoxA2 knockout embryos show
increased expression of Dkk-1 in the ectoderm at E7.5 (Kimura-
Yoshida et al., 2007). Using qRT-PCR analysis, we observed
that during NSB induction Dkk-1 transcript levels rise sharply at
day 5 from 200- to 5000-fold and then drop back down, consis-
tent with the role of Dkk-1 as an AN inducer.We performedELISA
to measure Dkk-1 protein levels in the medium and found levels
as high as 12 ng/ml (Figures 5A and 5B). A drastic reduction of
Dkk-1 at both mRNA and protein levels was observed as early
as 2 days after Sonic C25II treatment (Figures 5B and 5C).
To test whether DKK-1 is functionally involved during hESC
differentiation in FP specification, we added recombinant
Dkk-1 in combination with Sonic C25II and assessed FP marker
expression. Although treatment with Sonic C25II alone resulted
in a decrease of the AN marker BF1 and an upregulation of
Foxa2 (Figures 5D–5F), the addition of Dkk-1 caused a decrease
in Foxa2 message and protein and a more rapid rise in BF1 tran-
script (Figures 5D–5F). Conversely, addition of Dkk-1 antibody to
cells in the NSB protocol caused a significant delay and
decrease in the levels of BF1 expression. We next differentiated
hESCs in the presence of both Sonic C25II and Dkk-1 neutral-
izing antibody. Under these conditions, early transient induction
of BF1 transcript at day 5 is suppressed and accompanied by an
increase in Foxa2 levels (Figures 5E and 5G). Our data reveal
a critical window for FP specification during neural induction.
With the observation that DKK-1 expression can inhibit FOXA2
expression, we tested next whether the addition of DKK-1 block-
ing antibody can extend the window of competency for SHH
mediated FP induction. DKK-1 antibody was added at day 1,
day 5, and day 9 of differentiation. Exposure to SHHwas initiated
at the same time points and the expression of FOXA2 was
assayed after 9 days of SHH exposure. When DKK-1 is added
along with SHH at day 1, we see an increase in FOXA2+ cells.
However, when added at day 5 or day 9, we see no effect of
the DKK-1 antibody (Figures 5H and 5I). These data suggest
that high, early endogenous levels of Dkk-1 in the NSB protocol
suppress FP competency. Early treatment with SHH represses
Dkk-1 and enables differentiation toward FP lineage. However,Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc. 341
Figure 5. Dkk-1 Inhibits FP Induction
(A) qPCR for Dkk-1 expression in control NSB condition over time.
(B) ELISA measuring Dkk-1 protein levels in the media at days 5, 7, and 11 showing a decrease in Dkk-1 levels after Sonic C25II treatment, *p < 0.05, n = 3.
(C) qPCR for Dkk-1 expression in NSB+Sonic C25II condition over time.
(D and E) qPCR for BF1 (D) and Foxa2 (E) showing an increase in BF1 and decrease of Foxa2 after Dkk-1 addition and an increase in Foxa2when Dkk-1 antibody
is added.
(F) Immunostaining for Foxa2 showing a decrease in Foxa2+ cells when Dkk-1 is added. The scale bar represents 200 mm.
(G) qPCR for BF1 expression showing that Dkk-1 antibody treatment leads to a decreased expression at earlier time points (days 3–5).
(H and I) Early addition of DKK-1 antibody leads to an increase of FOXA2 expression, but has no effect when added at later time points. As shown in (I),
immunocytochemical data demonstrating that Dkk-1 treatment starting at day 5 of differentiation (or later) does not enhance SHH-mediated FOXA2 expression.
(J–K00) hESC transducedwith either control or BF1 shRNA (J and K), GFP is amarker of transduction (A0 and B0 ). When differentiated to neural tissue, a reduction of
BF1 is seen at the level of the protein compared to control (J00 and K00). Scale bars in (A) and (B) represent 100um; those in (J00) and (K00) represent 200 mm.
(L) qRT-PCR analysis at day 11 showed an increase in FPmarkers (Foxa2, Shh,Netrin-1, and F-Spondin) in the BF1 shRNA line compared to the control; p < 0.01,
n = 3.
(M) BF1 shRNA leads to an upregulation of FOXA2 seen at the level of the protein. The scale bar represent 200 mm. See also Figure S4.
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Floor Plate Induction from hESCsinhibition of DKK-1 at day 5 or later stages does not extend the
temporal window for FP induction.
BF1 Expression Represses FP Commitment
We have shown that adding SHH can lead to FP differentiation
at the expense of AN. Dkk-1 has been shown to specify BF1+
neurectoderm BF1 (Mukhopadhyay et al., 2001), and BF1 is
expressed in most neural cells upon NSB induction (Figures 4342 Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc.and 5). To test whether expression of the forkhead factor BF1
directly represses FP competency during neural induction, we
transduced hESCs with a BF1 shRNA construct (Fasano et al.,
2009; Shen et al., 2006) and derived clonal lines. BF1 is not highly
expressed in hESCs and there was no difference in cell
morphology or colony size (Figure S4). However, upon neural
differentiation of hESCs, there was a decrease in BF1 protein
expression (Figures 5J00 and 5K00) and an 80% decrease in BF1
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associated with deficits in proliferation and cell-cycle progres-
sion at the neural precursor stage, BF1 knockdown lines at the
hESC stage showed cell-cycle kinetics comparable to control
vector transduced lines (Figure S4). BF1 knockdown and control
hESCs were then differentiated to FP and subjected to qRT-PCR
analysis and immunocytochemistry for a panel of FP markers.
After 11 days of differentiation, there was a significant increase
in transcript levels of all FP markers in the BF1 shRNA condition
(Figure 5L) and greater than 90% of total cells expressed FOXA2
(Figure 5M).
We also generated hESC lines overexpressing BF1 using
a previously described vector (Fasano et al., 2009) and differen-
tiated them toward FP lineage. At day 11, compared to a control
GFP expressing clones, there was a reduction of FOXA2+ cells
and a decrease in FP marker expression (Figure S4). These
data demonstrate that BF1 expression inhibits the derivation of
hESC derived FP.
The A/P Axis of the FP Can Be Altered
by Caudalizing Agents
Although certain characteristics are shared among all FP cells,
such as Foxa2 and Netrin-1 expression, differences have been
reported between different regions of the floor plate along the
A/P axis (Placzek and Briscoe, 2005). Elegant studies in the
mouse have shown that specific enhancer elements direct Shh
expression in different regions along the A/P axis of the FP
(Jeong et al., 2005). We noticed that Six6 was coexpressed in
FOXA2+ cells (Figures S3E and S3F) and dramatically increased
during FP induction compared to NSB control conditions
(50,000-fold increase in mRNA levels at day 5 of differentiation;
Figure S3). Six6 has been shown to be a critical cofactor in regu-
lating SHH gene expression at an enhancer region known as
SBE2 that directs Shh expression specifically to the most ante-
rior aspect of the ventral brain (Jeong et al., 2008).
With no other reports available, we postulated Six6 as a puta-
tive marker of anterior FP identity. We next tested whether Six6
status of the hESC derived FP can be respecified in response to
known caudalizing agents such as FGF8, Wnt-1, and retinoic
acid. Each of these caudalizing factors was added in combina-
tion with SHH and the resulting tissue was assessed for expres-
sion of the FP markers Foxa2 and Netrin-1, the AN marker BF1,
and putative anterior FP marker Six6. FP generation was not
compromised in the presence of caudalizing factors. In fact,
the addition of Wnt-1 or RA significantly potentiated FP produc-
tion based on FOXA2 and Netrin-1 expression (Figures 6A and
6B). Enhanced expression of FP markers in the RA and Wnt-1
group was correlated with a dramatic reduction in BF1 and
SIX6 expression (Figure 6B). Colabeling studies were performed
to demonstrate that caudalizing factors indeed act within FP
cells to respecify AP identity. We observed a significant reduc-
tion in the percentage of FOXA2+ cells coexpressing SIX6 or
HESX1, with the Wnt-1 and RA conditions being the most
effective at suppressing anterior FP identity (Figures S3E and
S3F and data not shown).
We next assessed whether any of these conditions led to an
upregulation of midbrain FP and DA progenitor markers. The
different factors had varied effects on marker expression (Fig-
ure 6B). In particular, exposure to Wnt-1 resulted in a significantincrease in the midbrain FP markers Corin and Nov, as well as
increases in the DA progenitor markers Lmx1b, EN1, and
Ngn2. These data are in agreement with previous studies
showing that Wnt signaling is critical in the neurogenic response
of the midbrain FP (Joksimovic et al., 2009).
The identification of distinct enhancer elements directing SHH
expression to different regions along A/P axis of the embryo
(Jeong et al., 2008) enabled us to further probe regional identify
of hESC derived FP. To this end, we generated hESCs derived
FP in the presence or absence of Wnt-1 or FGF8 and transfected
the resulting tissue with two SHH enhancer constructs driving
LacZ expression in different A/P domains of the FP. The SBE1
construct directs SHH expression to the midbrain region of the
floor plate, whereas the SBE2 enhancer directs SHH expression
to the most anterior region of the FP where Six6 has been shown
to bind. In the absence of caudalizing factors (SHH C25II alone),
we observed LacZ expression after transfection with the SBE2
but not the SBE1 enhancer, supporting the hypothesis that
hESC-derived FP is anterior by default (Figure 6C). In contrast,
SBE2 activity was abolished upon treatment with Wnt1 or
FGF8, whereas SBE1 activity was induced under these condi-
tions. These data indicate that FGF8 or Wnt1 treatment induces
a shift in FP identity toward a more caudal, midbrain-like identity
(Figure 6C).
In conclusion, our data demonstrate that upon neural differen-
tiation, hESCs default toward AN fate in part by upregulating
DKK-1 and subsequently BF1 and that AN commitment actively
represses FP competency in hESC progeny. However, early
exposure to high levels of SHH reduces DKK-1 induction and
enables FP induction at the expense of AN. Human ESC-derived
FP is anterior by default but can be posteriorized in response to
caudalizing factors. This is summarized in Figure 6E.
DISCUSSION
An important finding of our study is the ‘‘default’’ nature and
anterior bias of the resulting FP tissue. The lack of any obvious
mesodermal intermediates in both NSB (Chambers et al., 2009;
Figure 4), and the FP (Figure 4) induction protocol presented
here, suggests that the in vitro derivation of neuroectoderm
and FP tissue is not dependent on any additional mesoderm
derived signals. Interestingly, FP induction occurs readily even
in the presence of SB431542, an inhibitor of TGFb/Activin/Nodal
signaling in contrast to data in zebrafish in which nodal is thought
to be essential for FP induction (reviewed in Placzek andBriscoe,
2005). The anterior default of the FP tissue reported here is
reminiscent of the anterior default observed in hESC-derived
neuroectodermal cells.
The A/P identity of FP cells remains a controversial topic in the
field; in particular, the anterior-most extension of the FP. Studies
in zebrafish and chick have shown that FP markers are not only
expressed in conventional FP cells but are also transiently de-
tected in FP cells that extend through the anterior diencephalon
terminating at the level of the preoptic area. The presence of
anterior FP cells has also been reported during mouse develop-
ment, and it has been suggested that anterior FP-like cells
exhibit characteristics distinct from those of posterior FP cells
(Placzek and Briscoe, 2005). Interestingly, several Wnts are
expressed in the developing FP, and Wnt signaling has beenCell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc. 343
Figure 6. hESC-Derived FP Can Be Shifted Along the A/P Axis
(A) Immunostaining reveals an increase in FOXA2 in response to FGF8, Wnt-1, and retinoic acid. The scale bar represents 200 mm.
(B) qPCR showing caudilizing agents such as FGF8, Wnt-1, and retinoic acid (RA) lead to an increase in Foxa2 and a reduction in Six6 compared to NSB+Sonic
C25II.
(C) qPCR for a panel of midbrain FP markers (Corin and NOV) and midbrain DA progenitor markers (Lmx1b, Ngn2, and EN1).
(D) FP cells were transfected with a SHH enhancer that drives expression to the anterior ventral axis (SBE2) ormidbrain ventral axis (SBE1). The default FP exhibits
SBE2 activity indicating an anterior location. This is abolished uponWnt1 and FGF8 addition and SBE1 activity is now seen suggesting a shift from anterior identity
to midbrain. The scale bar represents 200 mm.
(E) Schematic of FP versus AN specification during hESC differentiation. Neural differentiation is initiated upon exposure to Noggin and SB431542. SHH
exposure, starting at day 1 of differentiation, induces FP differentiation and via inhibition of DKK-1 and BF1 suppresses AN specification. The regional identity
of the resulting FP cells is anterior by default but posterior FP tissue can be induced in the presence of caudalizing factors such as Wnt-1, FGFF8, or RA.
See also Figure S5.
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FP development (Placzek and Briscoe, 2005) in agreement
with our data presented here. High levels of Wnt signaling induce
more posterior FP character, whereas low levels promote ante-
rior, FP-like identity and the expression of hypothalamic markers
(Kapsimali et al., 2004). Our data demonstrate coexpression of
FOXA2+ cells with anterior midline markers HESX1 and SIX6,
known to be expressed in hypothalamic and preoptic areas,
respectively. These data corroborate that hESC-derived FP
yields cells of anterior ventral midline identity. We further demon-
strate that colabeling of FOXA2with HESX1 and SIX6 is lost upon
exposure to extrinsic Wnts mimicking the AP patterning events
reported for ventral midline cells in themouse embryo (Kapsimali
et al., 2004). In addition to SIX6 and HESX1 expression, our mi-
croarray data identified several other candidate markers and
signaling molecules compatible with anterior FP-like identity.
For example, the expression of Fzd5 and Fzd8, enriched in our344 Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc.hESC FP data, is in agreement with the anterior expression of
these Wnt receptors during early mouse development (Burns
et al., 2008; Kim et al., 2001). Similarly BMP7, another marker
enriched in our hESC FP microarray data set, is known to be
critical in the specification of anterior versus posterior FP cells
during mouse development (Dale et al., 1999). Future studies
will be required to comprehensively map the in vivo expression
of all putative FP markers identified from our hESC-derived
FP cell population, both anterior FP markers and markers
expressed after Wnt-mediated caudalization.
To date, it has not been clearly shown whether expression of
AN markers inhibits the ability of cells to yield certain lineages.
In hESC derived neural rosette cells, expression of BF1 does
not preclude patterning toward posterior CNS fates including
HB9+ somatic motoneurons. However, the efficiency of gener-
ating caudal neuron fates is significantly reduced as compared
to BF1-negative rosettes (Elkabetz et al., 2008). Previous studies
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to differentiate into FP in response to SHH alone (Placzek et al.,
1993) and our studies also show an AN commitment render them
incapable of FP specification.
A key finding of our study is the dramatic induction of Dkk-1
during NSB-mediated neural differentiation. During neural differ-
entiation of mouse ESCs exposure to extrinsic Dkk-1 is known to
enhance AN induction under serum-free embryoid body (SFEB)
conditions (Watanabe et al., 2005). It is therefore likely that early
induction of endogenous DKK-1 during neural differentiation is
least in part responsible for the AN default phenotype observed
in hESCs. However, future studies will be required to address the
role of DKK-1 specifically in AN commitment. Our functional
studies demonstrate that inhibition of Dkk-1 with blocking anti-
bodies significantly improves FP yield. We demonstrated above
that addition of DKK-1 antibodies along with SHH at day 5 or
later time points is not sufficient to extend the temporal window
of FP competency (Figures 5H and 5I). Similarly, the addition of
WNTs (Wnt-1, Wnt3A, or GSK inhibitor [BIO]) to neural rosette-
stage cells was not sufficient to induce FP competency
(Figure S5). These data demonstrate that an early AN bias during
neural differentiation suppresses FP potential of hESC-derived
precursors.
Recent studies in the mouse suggest that some regions of the
FP, beyond key roles in neural patterning and axonal path
finding, may serve as a source of specific neuron types such
as midbrain dopamine neurons. Here, we demonstrate respeci-
fication of regional identity of hESC-derived FP toward midbrain
character based on the expression of midbrain-specific markers
and the activation of midbrain-specific SHH enhancer elements
and loss of anterior FP marker expression in FOXA2+ cells.
Although we do have preliminary evidence that hESC-derived
FP tissue can yield TH+/FOXA2+ putative midbrain DA neurons
(Figure S5), future studies will be required to systematically
compare the neurogenic properties of hESC-derived FP tissue
and to explore the potential of hESC-derived FP as a source of
authentic human midbrain dopamine neurons. In conclusion,
our study yields insights into the induction and regional specifi-
cation of human FP versus AN fates and establishes hESCs as
a powerful cell source for creating a functional organizer tissue.
The results further illustrate how use of the dual SMAD-inhibition
protocol can be effectively adapted for controlling alternative cell
fate choice during hESC neural differentiation and enables
precise mechanistic studies on cell fate specification in the
CNS and beyond.
EXPERIMENTAL PROCEDURES
Cells and Culture Conditions
hESCs (WA-09; passages 35-45) were cultured on mouse embryonic fibro-
blasts plated at 12,0000–15,000 cells/cm2 (MEFs, Global Stem). A medium
of DMEM/F12, 20% knockout serum replacement (GIBCO), 0.1 mM b-mer-
captoethanol, and 6 ng/mL FGF-2 was changed daily. Cells were passaged
with 6 U/mL of dispase in hESCs media, washed, and replated at a dilution
of 1:5 to 1:10.
Neural Induction
For MS5 induction, established methods previously reported were used (Per-
rier et al., 2004). Feeder-free neural induction was carried out as previously
described (Chambers et al., 2009). For FP induction, Sonic C25II was added
at 200 ng/ml. In some experiments, DKK-1 (R&D; 100 ng/ml) FGF8 (R&D;50 ng/ml), Wnt-1 (Peprotech; 50 ng/ml) and retinoic acid (R&D; 1 mM) were
added.
Quantitative Real-Time PCR
Total RNA was extracted with an RNeasy kit (QIAGEN). For each sample, 1 ug
of total RNA was treated for DNA contamination and reverse transcribed with
the Superscript III (Invitrogen). Amplified material was detected with Taqman
probes and PCRmix (ABI) on aMastercycler RealPlex2 (Eppendorf). All results
were normalized to a HPRT control and are from three technical replicates of
three independent biological samples at each data point.
Micorarray Analysis
Total RNA was isolated at days 2, 3, 5, 7, and 11 of differentiation from both
control (NSB) and FP (NSB+Shh C25II) with Trizol (Invitrogen). Three biological
replicates per time point were used. All samples were processed by the
MSKCCGenomics Core Facility and hybridized on Illumina human six oligonu-
cleotide arrays. Normalization and model-based expression measurements
were performed with the Illumina analysis package (LUMI) available through
open-source Bioconductor project (www.bioconductor.org) within the statis-
tical programming language R (http://cran.r-project.org/). A pairwise compar-
ison between NSB and NSB+Sonic was performed with the linear models for
microarray data package (LIMMA) available through Bioconductor. Genes
found to have an adjusted p value < 0.05 and a fold change greater than 2
were considered significant. Expression differences are reported as the log2
of the fold change. Gene Ontology enrichment was determined by entering
gene lists into the Database for Annotation, Visualization, and Integrated
Discovery (DAVID; http://www.david.niaid.nih.gov) (Huang et al., 2009 and
Dennis et al., 2003). Timing of maximal andminimal expression was calculated
as previously reported (Venezia et al., 2004). In brief, a regression line was fit to
both the NSB+Sonic C25II and NSB conditions. From these trend lines, genes
were categorized on the basis of which time point its maximal and minimal
expression occurred.
Microscopy, Antibodies, and Flow Cytometry
Tissue was fixed with 4% paraformaldehyde and picric acid for 15 min,
washed with PBS, permeablized with 0.3% Triton X in PBS, and blocked
with 10% Donkey Serum. Primary antibodies used for microscopy included
PAX6 (Covance), TUJ1 (Covance), ZO1 (Zymed), BF1 (FOXG1, gift E.Lai), TH
(Pelfreez), Nkx6.1 (DSHB) and Foxa2 (SantaCruz), SIX6 (Sigma), and HESX1
(Sigma).
Vector Design and Lentiviral Production
A third-generation lentiviral vector (Lois et al., 2002) was modified to express
a BF1 ORF from the Ub-C promoter (Fasano et al., 2009) and a BF1 shRNA
from the H1 promoter as described (Fasano et al., 2007; Ivanova et al.,
2006). Foxg1 shRNA constructs were used as previously described (Shen
et al., 2006). Viral particles were generated as previously described (Fasano
et al., 2007).
Dissection of Primary Explants
E8.5, TP Taconic Swiss Webster females were dissected and embryos were
removed. Neurectodermal tissues were dissected and left as chunks plated
on top of FP cells. For neurite growth assay, E12.5 Sprague-Dawley rat cere-
bellar plate tissue was dissected and plated on top of hESC-derived FP cells or
control neuroectodermal cells (NSB protocol). Outgrowth from rat explants
tissue was analyzed at day 3 of coculture.
Conditioned Media and ELISA
hESCs were differentiated to neural or FP cells, Shh was removed a day 6, and
the media was harvested at both day 9 and day 11 of cultures. With a human
Netrin-1 ELISA kit (Axxora) in accordance with the manufacturer’s protocol,
Netrin-1 protein levels were detected. For coculture experiments, the media
was filtered and added to cultures straight or a 1:2 dilution in fresh media.
Statistical Analysis
Results shown are mean ± SEM. Asterisks and pound signs identify experi-
mental groups that were significantly different from control groups by a t test,Cell Stem Cell 6, 336–347, April 2, 2010 ª2010 Elsevier Inc. 345
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Floor Plate Induction from hESCsone-way ANOVA, or two-way ANOVA with a Bonferroni correction for multiple
comparisons (p value, 0.05), where applicable.
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geo/) under accession number GSE20573.
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